Saturday 17 October 2026
Export PYPD’s income statement to Excel — free account
PolyPid Ltd.
PYPD Healthcare Biotechnology
In the quarter to June 2026, EPS grew 55.1%, free cash flow fell 65.0% and total debt fell 88.4%, each against the same quarter a year earlier.
4.75
0.15
−3.06%
Follow PYPD
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
1.97 | 1.31 | 0.83 | 1.66 | 4.31 | 16.41 | 10.62 | 2.18 | 5.57 | 10.75 |
Net Debt/EBITDA |
0.39 | 0.32 | (0.23) | 0.04 | 0.78 | 1.78 | 1.53 | 0.42 | 1.32 | 1.75 |
Debt/Assets |
4.43% | 29.43% | 67.54% | 44.66% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.09 | 0.97 | (4.95) | 1.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.82 | 0.76 | 0.72 | 0.87 | 0.76 | 0.50 | 2.51 | (2.82) | 0.21 | 0.70 |
Capex/Depreciation |
(0.14) | (0.05) | (0.11) | (1.03) | (2.37) | (0.77) | (0.93) | (7.48) | 0.00 | 0.00 |
Interest Coverage |
— | — | — | — | — | — | — | — | (260.38) | (114.63) |
| (366.29%) | (1,038.73%) | (1,278.60%) | (189.32%) | (78.36%) | 577.80% | 8.16% | (6.95%) | 96.48% | 22.84% | |
| (143.79%) | (142.99%) | (115.45%) | (112.69%) | (70.95%) | (78.31%) | (28.63%) | 35.09% | (614.88%) | (66.32%) | |
ROIC |
0.00% | 0.00% | (533.88%) | (562.36%) | (802.55%) | (58.83%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(271.57%) | (291.18%) | (372.77%) | (265.70%) | (120.02%) | (85.47%) | (22.32%) | 56.17% | (323.32%) | (80.45%) |
Average Days of Receivables |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Free Cash Flow per Share |
(1.72) | (3.73) | (12.41) | (55.72) | (56.21) | (70.13) | (975.24) | (1,056.26) | (0.93) | (0.73) |
Cash per Share |
0.80 | 2.67 | 3.99 | 20.24 | 52.29 | 140.60 | 1,442.99 | 403.64 | 1.35 | 1.34 |
Shareholders Equity per Share |
0.67 | 1.30 | (1.49) | 9.00 | 57.68 | 228.07 | 998.98 | (4,369.52) | (2.16) | 0.76 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.67 | 1.30 | (1.49) | 9.00 | 57.68 | 228.07 | 998.98 | (4,369.52) | (2.16) | 0.76 |
Free Cash Flow |
(28.09) | (22.04) | (17.43) | (36.08) | (35.04) | (22.38) | (18.24) | (19.75) | (12.31) | (9.73) |
Working Capital |
7.49 | 3.89 | (1.22) | 5.64 | 26.74 | 44.32 | 24.82 | 4.35 | 15.37 | 16.56 |
Capital Expenditures |
(0.21) | (0.08) | (0.20) | (1.77) | (2.65) | (0.78) | (0.88) | (3.07) | (1.88) | (0.54) |
Net Current Asset Value |
3.89 | (0.96) | (11.40) | (5.95) | 26.54 | 44.13 | 12.33 | (88.16) | (32.92) | 9.08 |
| Other line items | ||||||||||
Quick Ratio |
1.70 | 1.25 | 0.77 | 1.53 | 4.04 | 15.59 | 10.46 | 2.05 | 5.34 | 10.47 |
Depreciation/Fixed assets |
0.29 | 0.27 | 0.24 | 0.19 | 0.13 | 0.17 | 0.15 | 0.07 | 0.07 | 0.15 |
Cash ROIC |
(111.97%) | (71.29%) | (125.46%) | (118.18%) | (51.11%) | (19.02%) | (39.94%) | 26.63% | 114.80% | (34.99%) |
Accounts Receivable Turnover |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1.70) | (3.71) | (12.27) | (52.99) | (51.95) | (67.68) | (928.24) | (891.87) | (0.93) | (0.73) |
Capex per Share |
(0.01) | (0.01) | (0.14) | (2.73) | (4.26) | (2.45) | (47.01) | (164.38) | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 |
Average Payables |
2.63 | 1.59 | 0.96 | 2.64 | 2.56 | 1.28 | 1.36 | 1.36 | — | — |
Average Assets |
23.76 | 20.30 | 20.67 | 35.10 | 60.04 | 54.80 | 24.12 | 16.86 | 9.62 | 21.11 |
Average Common Equity |
9.33 | 2.79 | 1.87 | 20.89 | 54.37 | (7.43) | (84.67) | (85.18) | (61.30) | (61.30) |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Columns are period end dates